Molecular Prognostic Prediction for Locally Advanced Nasopharyngeal Carcinoma by Support Vector Machine Integrated Approach
暂无分享,去创建一个
Yan Zhang | Quentin Liu | Jie Xu | Quentin Liu | Y. Zeng | M. Hong | Ming-Yuan Chen | X. Wan | Ming-Yuan Chen | Yi-Xin Zeng | Jie Xu | Ming-Huang Hong | Yan Zhao | Xin-Juan Fan | H. Cai | Yan Zhang | Xiang-yuan Wu | Hong-Bo Li | Hong-Min Cai | Xiang-Bo Wan | Yan Zhao | Xin-Juan Fan | Xiang-Yuan Wu | Hong-Bo Li
[1] Billie Anderson,et al. Comparison of the predictive qualities of three prognostic models of colorectal cancer. , 2010, Frontiers in bioscience.
[2] Jian-ming Li,et al. Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer , 2010, Cancer biology & therapy.
[3] Jordi Giralt,et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. , 2010, The Lancet. Oncology.
[4] Zlatko Trajanoski,et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Sun,et al. Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.
[6] Ruth Ladenstein,et al. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. , 2009, The Lancet. Oncology.
[7] I. Wistuba,et al. Phase II randomized study of biomarker-directed treatment for non-small cell lung cancer (NSCLC): The BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) clinical trial program. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] B. Teh,et al. Complexity of tumor vasculature in clear cell renal cell carcinoma , 2009, Cancer.
[9] H. Wada,et al. D2-40-Positive Lymphatic Vessel Density Is a Poor Prognostic Factor in Squamous Cell Carcinoma of the Lung , 2009, Annals of Surgical Oncology.
[10] Christophe Lemetre,et al. An introduction to artificial neural networks in bioinformatics - application to complex microarray and mass spectrometry datasets in cancer studies , 2008, Briefings Bioinform..
[11] Jie Xu,et al. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells. , 2008, Carcinogenesis.
[12] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[13] J. Tang,et al. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] Andrew Kusiak,et al. Cancer gene search with data-mining and genetic algorithms , 2007, Comput. Biol. Medicine.
[15] Jeremy J. W. Chen,et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.
[16] W. Cho,et al. Nasopharyngeal carcinoma: molecular biomarker discovery and progress , 2007, Molecular Cancer.
[17] S. Mukherjee,et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.
[18] J. Grandis,et al. Epidermal growth factor receptor biology in head and neck cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] W. Sauerbrei,et al. Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.
[20] Jun Ma,et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: A pooled data analysis of two phase III trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Russ Wolfinger,et al. Generalizable mass spectrometry mining used to identify disease state biomarkers from blood serum , 2003, Proteomics.
[22] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[23] Zong Yong. Study on the Role of Epstein-Barr Virus Playing in Nasopharyngeal Carcinogenesis , 2002 .
[24] O. Kallioniemi,et al. Tissue microarrays (TMAs) for high‐throughput molecular pathology research , 2001, International journal of cancer.
[25] V. Vapnik,et al. Bounds on Error Expectation for Support Vector Machines , 2000, Neural Computation.
[26] Jun Ma,et al. A comparison of the Chinese 1992 and fifth‐edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma , 2000, Cancer.
[27] R. Day,et al. Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival , 1998 .
[28] R. Day,et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. , 1998, Journal of the National Cancer Institute.
[29] W. Enker,et al. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] Pelayo Vilar,et al. Nasopharyngeal Carcinoma , 1966 .